325 related articles for article (PubMed ID: 9845827)
1. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
2. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
3. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
[TBL] [Abstract][Full Text] [Related]
4. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
6. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis.
Wang HH; Lin CY; Huang TP
Nephrol Dial Transplant; 2003 Jun; 18(6):1181-9. PubMed ID: 12748353
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
Mlambo NC; Hylander B; Brauner A
Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
[TBL] [Abstract][Full Text] [Related]
8. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
9. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
10. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
Lin CY; Lin CC; Huang TP
Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
12. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
13. Effect of repeated peritonitis on peritoneal membrane function in children on chronic peritoneal dialysis.
Wang HH; Lin CY
Zhonghua Yi Xue Za Zhi (Taipei); 2002 May; 65(5):205-11. PubMed ID: 12166764
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.
Wang T; Ghen YG; Ye RG; Mai WY; Zhen ZH; Li HQ
Adv Perit Dial; 1995; 11():11-4. PubMed ID: 8534680
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
17. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
Szeto CC; Wong TY; Lai KB; Chow KM; Li PK
Perit Dial Int; 2002; 22(2):265-7. PubMed ID: 11990414
[No Abstract] [Full Text] [Related]
19. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Zhang L; Hao JB; Ren LS; Ding JL; Hao LR
Lab Invest; 2014 Aug; 94(8):839-50. PubMed ID: 24862968
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients.
Zarrinkalam KH; Stanley JM; Gray J; Oliver N; Faull RJ
Kidney Int; 2003 Jul; 64(1):331-8. PubMed ID: 12787426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
